These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12934492)

  • 1. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
    Mendeleeva LP
    Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of bone marrow transplantation in the treatment of leukemia].
    Robak T
    Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia.
    Fauser AA; Köchling G; Digel W; Finke J; Thiel M; Heinz J; Bross KJ; Dölken G; Mertelsmann R
    Bone Marrow Transplant; 1993; 11 Suppl 1():83. PubMed ID: 8448558
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation. The state of the art.
    Thomas ED
    Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
    [No Abstract]   [Full Text] [Related]  

  • 5. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
    Schneider EM; Dörries K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1271-3. PubMed ID: 8382856
    [No Abstract]   [Full Text] [Related]  

  • 6. [New therapeutic possibilities for leukemia in adults. Indications and progress measures for allogeneic bone marrow transplantation].
    Brinch L; Evensen SA; Albrechtsen D; Egeland T
    Tidsskr Nor Laegeforen; 1991 Jan; 111(3):316-9. PubMed ID: 2000611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
    Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T
    Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation.
    De Witte T; Vreugdenhil G; Schattenberg A
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):57-60. PubMed ID: 8351721
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Ringdén O; Horowitz MM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2989-92. PubMed ID: 2650409
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation for leukemia after conditioning with busulfan and cyclophosphamide. Bone marrow morphology in the early recovery phase.
    Cao DC; Tutschka PJ
    Chin Med J (Engl); 1991 Apr; 104(4):267-76. PubMed ID: 2065543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
    Buckner CD; Clift RA; Appelbaum FR; Storb R; Petersen FB; Sanders JE; Thomas ED; Hansen JA
    Bone Marrow Transplant; 1991; 7 Suppl 2():6-8. PubMed ID: 1878723
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequency and indication of unrelated bone marrow transplants in Europe. European Group of Bone Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1993; 11 Suppl 1():62-5. PubMed ID: 8448551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recovery.
    Van der Lely N; De Witte T; Raemaekers J; Schattenberg A; Haanen C
    Bone Marrow Transplant; 1989 Mar; 4(2):163-6. PubMed ID: 2650786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies on the role of bone marrow transplantation for patients with hematopoietic malignancies.
    Geller RB
    Mt Sinai J Med; 1994 Jan; 61(1):13-22. PubMed ID: 8183287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual physician practice variation in hematopoietic cell transplantation.
    Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
    J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplants in ALL.
    Barrett AJ; Horowitz MM
    Bone Marrow Transplant; 1992; 10 Suppl 1():30-6. PubMed ID: 1521088
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.
    Bernasconi C; Lazzarino M; Canevari A; Morra E; Castelli G; Brusamolino E; Alessandrino EP; Pagnucco G; Orlandi E; Castagnola C
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439
    [No Abstract]   [Full Text] [Related]  

  • 20. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.
    Santos GW
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():236-9. PubMed ID: 2653511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.